JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chêne, L.
Right arrow Articles by Israël, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chêne, L.
Right arrow Articles by Israël, N.

 Previous Article  |  Next Article 

Journal of Virology, September 1999, p. 7533-7542, Vol. 73, No. 9
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Thymocyte-Thymic Epithelial Cell Interaction Leads to High-Level Replication of Human Immunodeficiency Virus Exclusively in Mature CD4+ CD8minus CD3+ Thymocytes: a Critical Role for Tumor Necrosis Factor and Interleukin-7

L. Chêne,1 M.-T. Nugeyre,1 E. Guillemard,1 N. Moulian,2 F. Barré-Sinoussi,1 and N. Israël1,*

Unité de Biologie des Rétrovirus, Institut Pasteur, 75724 Paris Cedex 15,1 and Laboratoire de Physiologie Thymique, Hôpital Marie-Lannelongue, CNRS ESA-8078, 92350 Le Plessis-Robinson,2 France

Received 8 March 1999/Accepted 1 June 1999


    ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

This work aims at identifying the thymocyte subpopulation able to support human immunodeficiency virus (HIV) replication under the biological stimuli of the thymic microenvironment. In this report we demonstrate that interaction with thymic epithelial cells (TEC) induces a high-level replication of the T-tropic primary isolate HIV-1B-LAIp exclusively in the mature CD4+ CD8- CD3+ thymocytes. Tumor necrosis factor (TNF) and interleukin-7 (IL-7), secreted during this interaction, are critical cytokines for HIV long terminal repeat transactivation through NF-kappa B-dependent activation. TNF is the major inducer of NF-kappa B and particularly of the p50-p65 complex, whereas IL-7 acts as a cofactor by sustaining the expression of the p75 TNF receptor. The requirement for TNF is further confirmed by the observation that the inability of the intermediate CD4+ CD8- CD3- thymocytes to replicate the virus is associated with a defect in TNF production during their interaction with TEC and correlates with the absence of nuclear NF-kappa B activity in these freshly isolated thymocytes. Addition of exogenous TNF to the intermediate thymocyte cultures induces NF-kappa B activity and is sufficient to promote HIV replication in the cocultures with TEC. The other major subpopulation expressing the CD4 receptor, namely, the double-positive (DP) CD4+ CD8+ CD3± thymocytes, despite the entry of the virus, do not produce a significant level of virus, presumably because they are unresponsive to TNF and IL-7. Together, these data suggest that in vivo, despite an efficient entry of the virus in all the CD4+ subpopulations, a high viral load may be generated exclusively within the mature CD4+ CD8- CD3+ subset of thymocytes. However, under conditions of inflammatory response after infection, TNF might also be present in the intermediate thymocyte compartment, leading to efficient HIV replication in these cells.


    INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

The progression of human immunodeficiency virus (HIV) infection is clearly associated with an increase in the viral load in plasma and a progressive depletion of CD4+ T cells. One explanation for this depletion is the exhaustion of T-cell turnover, which must occur at a very high rate to replace the CD4+ lymphocytes permanently destroyed during HIV infection (15, 23, 59).

More recent studies on the kinetics of the increase in the number of CD4+ T cells after triple-combination therapies demonstrated that the mechanisms of T-cell depletion during HIV infection are more complex (36, 40). The depletion observed in the blood compartment may result from a combination of the trapping of these cells in lymph nodes and inflamed tissues (3, 40) and a failure of T-cell regeneration in primary lymphoid organs and particularly in the thymus (17, 36, 61). Although T-cell development can occur via extrathymic pathways, generation of the complete T-cell repertoire, required for immune system function, is dependent upon the thymus. This organ was shown to be still functional in adults, albeit less actively (17). HIV infection is accompanied by a decrease in thymic function (17), and antiviral therapies contribute to immune system reconstitution by a recovery of naive T cells, probably through expansion of preexisting cells and thymic production of new cells (3, 37, 61, 65). However, this renewal occurs slowly (40), suggesting, in some cases, a severe impairment of T-cell progenitors, probably depending on the stage of the disease and the age of the patient. Indeed, observations of thymuses from HIV-infected pediatric patients, who underwent a rapid progression to AIDS, led to the conclusion that insult to this organ induces a severe thymocyte depletion associated with a profound disorganization of the epithelial network (27, 41, 44). Modification of the structure of the thymus and loss of thymocytes were also found in thymic tissues from infected macaques (39) and from SCID-hu mice (2, 48). This profound deterioration was also confirmed by the inability to completely restore thymopoiesis in infected thymuses from SCID-hu mice treated with highly active antiretroviral therapy (61).

For a better understanding of the immunopathogenesis associated with HIV infection of the thymus, we previously examined the factors and mechanisms controlling HIV replication in this organ (14, 45). The goal of the present work was the identification of thymocyte subpopulations that allow efficient HIV replication in the thymic environment. This relates to the general question of the control of spreading of the virus in this organ and its consequences for the peripheral viral load and thymopoiesis.

Using an autologous mixed culture with thymic epithelial cells (TEC) and the total population of thymocytes, we previously demonstrated that interaction of infected thymocytes with TEC is a prerequisite for high-level HIV replication (45). Cytokines secreted during this TEC-thymocyte interaction were first identified as tumor necrosis factor (TNF), interleukin-1 (IL-1), IL-6, and granulocyte-macrophage colony-stimulating factor (GM-CSF), and a role for IL-7 was demonstrated later (14). Furthermore, we provided evidence that NF-kappa B activation is required for a high-level replication of HIV in thymocytes (14) by demonstrating that HIV provirus with its two kappa B sites deleted fails to replicate in thymocytes cocultured with TEC. NF-kappa B is composed of homo- and heterodimers of members of the Rel/NF-kappa B family (p65, c-Rel, Rel B, p50 and its precursor p105, and p52 and its precursor p100) (5, 35). These dimers are sequestered in the cytosol of unstimulated cells via interactions with a family of inhibitory proteins called Ikappa Bs (Ikappa Balpha , Ikappa Bbeta , and Ikappa Bvarepsilon ) (60). Following activation by various immune and inflammatory stimuli, Ikappa B molecules are degraded through the ubiquitin-proteasome pathway, allowing nuclear translocation of NF-kappa B and activation of its target genes (32, 35). We previously demonstrated, using the total population of thymocytes, that TNF in association with IL-7 induced the p50-p65 activity observed in the nuclear extracts of these cells.

The data obtained in our coculture system with TEC and the total population of thymocytes did not indicate, however, whether all the subpopulations expressing the CD4 receptor were able to produce virus at a high level in this partially reconstituted thymic environment. This is an important question in view of the conflicting data found in the literature. A number of in vitro studies have shown that all the human CD4+ thymocytes are susceptible to infection (16, 20, 52, 55, 56). Controversial in vivo studies report a specific infection of mature (41) or immature (44) thymocytes within the thymuses from infected infants. In thymuses from macaques infected with simian immunodeficiency virus, particles were detected either in the cortical area (7) or mainly in the medullary area (63). In the SCID-hu mouse model, viral DNA sequences were detected by PCR analysis in all the thymocytes expressing the CD4 receptor (30, 49). However, the kinetics of replication in the different subpopulations was shown to vary according to the viral isolates (10, 49), and this is very probably related to the distribution of the chemokine receptors on the human thymocyte subsets and to their usage by the viral isolates (9, 31, 42, 64). However, an efficient entry of the virus does not necessarily lead to a productive infection. We used the T-tropic primary isolate HIV-1B-LAIp, which is able to enter all the CD4+ subpopulations of thymocytes (since this isolate preferentially uses the CXCR4 coreceptor), to test its capacity to replicate in these distinct subpopulations.

We showed that the mature CD4+ CD8- CD3+ subpopulation is the only one able to sustain a high level of HIV replication when cocultured with TEC. TNF and IL-7 were confirmed to be the major coinducers of replication in these cells through induction of the p50-p65 complex of NF-kappa B. We also provide evidence that IL-7 mediates TNF-induced NF-kappa B activation by sustaining the expression of the p75 TNF receptor.

The other CD4+ subpopulations do not produce significant amounts of the virus during their coculture with TEC either because of their unresponsiveness to the cytokines (double positive) or because of the defect of TNF production (intermediate [33]) during their interaction with TEC. GM-CSF, mainly secreted by TEC, strongly amplifies HIV replication in the intermediate subset but has no effect on the mature subset.


    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Reagents. (i) Antibodies used for selection. To enrich the different thymic subpopulations by negative selection, the following monoclonal antibodies were used: CD3 (X35), CD8 (B9.11), CD83 (HB15A), CD10 (ALB 1), and CD34 (QBEND 10) (Immunotech, Marseille, France); OKT4A (Ortho Diagnostic Systems Inc., Raritan, N.J.); and CD14 (MPhi P9) (Becton Dickinson & Co., San Jose, Calif.). CD4-PE (13B8.2) and CD8-FITC (B9.11) were used for positive selection of the DP thymocytes.

(ii) Antibodies used for immunostaining. To characterize thymic subpopulations and TEC, monoclonal antibodies conjugated with the fluorescent dyes CD3-ECD (Coulter Corp., Hialeah, Fla.) or CD3-fluorescein isothiocyanate (FITC), CD4-phycoerythrin 7 (PE) (13B8.2), CD8-FITC (B9.11), CD83-PE (HB15a) (Immunotech), and CD14-FITC (RMO52) (Becton Dickinson) were used, and for indirect staining, CD7 (8H8.1), CD10 (ALB 1), CD34 (QBEND 10), Cytokeratin (KL1) (Immunotech), and Vimentin (vim3B4) (Boehringer Mannheim, Meylan, France) were revealed with goat anti-mouse immunoglobulin G (IgG) (H+L) F(ab')2-FITC (Immunotech). Expression of the two TNF receptors, p55 and p75, were determined on CD4+ mature and intermediate thymocytes by using TNF-receptor I (RI)-FITC (p55) (16803.1) and TNF-RII-FITC (p75) (22235.3) antibodies (R&D Systems). Negative controls for these immunostaining reactions were performed with mouse IgG1 (MARK1) and IgG2a (U7.27) antibodies. Conjugated mouse IgG1-PE (679.1Mc7), IgG1-FITC (679.1Mc7), goat anti-rabbit-FITC, and goat anti-mouse-FITC antibodies were purchased from Immunotech, and IgG1-ECD was from Coulter Corp. Direct and indirect immunostaining was analyzed by cytofluorometry with an EPICS Profile II fluorometer (Coulter Corp.).

(iii) Cytokines. Human recombinant cytokines GM-CSF, IL-1beta , and TNF were purchased from Genzyme Corp. (Cambridge, Mass.); IL-6 and IL-7 were purchased from R&D Systems (Minneapolis, Minn.). Cytokines were used at the following concentrations: IL-6, 10 ng/ml; TNF-alpha , 10 ng/ml; IL-1beta , 10 ng/ml; IL-7, 0.5 ng/ml; and GM-CSF, 20 ng/ml.

Cell culture conditions. (i) Preparation of TEC. Thymic fragments were obtained from HIV-1-seronegative children (aged 6 days to 2 years) undergoing elective cardiac surgery. TEC were obtained by the procedure of Rothe et al. (45). The dispersed TEC were seeded in a selective medium: McCoy's 5A (GIBCO) containing 10% fetal calf serum (FCS), 1 mM L-glutamine, 50 µg of penicillin-streptomycin per ml, 100 µg of neomycin per ml, 5 × 10-5 M beta -mercaptoethanol, 20 ng of epidermal growth factor (Sigma) per ml, 500 ng of hydrocortisone (Sigma) per ml, and 5 × 10-9 M cholera toxin (Interchim, Montluçon, France) (11). Prior to the coculture, TEC were maintained in the selective medium described above. An antikeratin antibody stained more than 95% of cells in the TEC-enriched population, confirming their epithelial characteristics (45).

(ii) Preparation of thymocyte subpopulations. Preparation of the total population of thymocytes has already been described (45). Except for the DP, most of the CD4-expressing subpopulations were obtained by negative selection. Mature CD4+ CD8- CD3+ thymocytes were obtained after three depletion cycles with anti-CD8, anti-CD10, and anti-CD34 antibodies and anti-mouse IgG-coated magnetic beads (Immunotech). Immature CD4± CD8- CD3- thymocytes were obtained after three depletion cycles with anti-CD3 and anti-CD8, anti-CD14, and anti-CD83 antibodies followed by anti-mouse IgG-coated magnetic beads. Anti-CD83 was used to remove dendritic cells. DP thymocytes were enriched by fluorescence-activated cell sorting with CD4 and CD8 antibodies in an Elite (Coulter) cell sorter. The antibodies that we used in this positive selection did not induce activation, since no replication after cell activation was detectable in these cells. In addition, each subpopulation obtained by negative selection was further purified by depleting monocyte/macrophage and dendritic cells with CD14 and CD83 antibodies and anti-mouse IgG-coated magnetic beads (Immunotech).

(iii) Mixed-culture procedure. Autologous coculture between TEC and infected thymocytes, either the total population or each of the enriched CD4+ subpopulations, was performed 3 days after thymus excision. A ratio of 4 × 106 thymocytes/5 × 104 TEC in 1 ml/well (24 wells/plate) was used in all the experiments.

The coculture medium was McCoy's 5A (GIBCO) containing 10% fetal calf serum (FCS), 1 mM L-glutamine, 50 µg of penicillin-streptomycin per ml, and 100 µg of neomycin per ml. In some experiments, cytokines were added at the start of the coculture.

Infection of thymocytes with HIV-1B-LAIp. All infections were performed with the primary isolate HIV-1B-LAIp (p is for primary isolate) (6). A total of 4 × 106 (for most experiments) or 2 × 106 (for the experiment in Fig. 4) thymocytes were infected at a multiplicity of infection of about 0.001 for 1 h at 37°C. The thymocytes were then washed three times with RPMI 1640 containing 10 mM HEPES, resuspended in culture medium, and cultured alone or with TEC in the presence or absence of cytokines. HIV-1 p24gag antigen concentration was determined in culture supernatants by using a p24gag antigen detection kit (Coulter HIV-1 p24 antigen assay) as specified by the manufacturer.

Electrophoretic mobility shift assay. Total-cell extracts were obtained as previously described (24). Briefly, 5 × 106 thymocytes under different culture conditions were harvested and washed in phosphate-buffered saline, lysed with 30 µl of lysis buffer for 15 min, and then centrifuged at 13,000 × g for 10 min. The protein concentration in the cell lysate was determined by using the Bradford reagent (Bio-Rad Laboratories, Ivry sur Seine, France).

For the band shift assay, the binding-reaction mixture was prepared by adding, in the following order, the binding buffer (20 mM HEPES, 2 mM dithiothreitol, 60 mM KCl, 0.01% Nonidet P-40, 0.1 mg of bovine serum albumin, 4% Ficoll), 0.4 µg of sonicated salmon sperm, 10 µg of protein extract, and 30,000 cpm of 32P-labelled DNA probe (corresponding to 0.25 ng of probe). The sequence of the oligonucleotides used was 5' GACAGAGGGGGACTTTCCGAGAGG    GTCTCCCCTGAAAGGCTCTCCCT 5'

where the NF-kappa B consensus binding sequence is indicated in bold type.

Specific binding was controlled by competition with a 40-fold excess (10 ng) of the same nonlabeled oligonucleotide added to the protein extract before starting the binding reaction. To identify the subunits constituting NF-kappa B complexes, specific antibodies against p50, p65, and RelB were used. p50 and p65 antibodies were a kind gift from A. Israël (Pasteur Institute, Paris, France), and RelB antibody was provided by Santa Cruz Biotechnology (Santa Cruz, Calif.). Antibodies were added to the protein extract, and the mixture was incubated for 15 min at 4°C before further incubation with the radiolabeled probe.

Statistical analysis. The relative role of each cytokine in HIV replication within a given thymocyte subpopulation was statistically analyzed by the nonparametric test of Mann-Whitney. The level of significance was set at P = 0.05.


    RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Enrichment of CD4+ thymocyte subpopulations. To study whether the high-level replication observed in total thymocytes in coculture with TEC is a feature only of a specific thymocyte subset defined by the maturation state, we enriched the distinct thymocyte subpopulations expressing CD4 in the absence of cell activation (see Materials and Methods). Figure 1 represents the characterization by flow cytometry analysis of these enriched subpopulations according to their surface expression of CD4, CD8, and CD3.


View larger version (31K):
[in this window]
[in a new window]
  		FIG. 1.   Characterization of the CD4+ thymic subpopulations according to their expression of CD4, CD8, and CD3. Freshly isolated total thymocytes (A) as well as immature (TN [CD4- CD8- CD3-] and intermediate [CD4+ CD8- CD3-]) (B), double-positive CD4+ CD8+ CD3± (C), and mature CD4+ CD8- CD3+ (D) thymocytes were characterized to demonstrate purity. These various populations were immunophenotyped for CD4 (PE) and CD8 (FITC) and subsequently analyzed by flow cytometry. The quadrant lines were set by the background signals obtained with isotype-matched negative controls. Percentages of cells found in each quadrant are indicated. The histograms (bottom) show CD3 (EDC) surface staining of each thymocyte population and the percentage of CD3+ cells. This experiment is representative of three experiments performed on three different thymuses.

Immature CD4+ thymocytes were enriched by negative selection of total thymocytes with antibodies against CD8 and CD3, to discard the mature CD4+ CD8- CD3+ and the DP CD4+ CD8+ CD3± thymocytes. As shown in Fig. 1B, this immature population was composed of two main subsets previously described in the human thymus (33): the immature triple-negative (TN) subset (CD4- CD8- CD3-) and the intermediate subset (CD4+ CD8- CD3-), which in this experiment made up 51% (mean, 38% ± 10.6% for 13 thymuses) and 48% (mean, 57.3 ± 10.8% for 13 thymuses) of the thymocytes, respectively. Enrichment for DP thymocytes was performed by fluorescence-activated cell sorting with CD4 and CD8 antibodies. As shown in Fig. 1C, an enrichment of 94% was obtained. CD3 expression was observed in 55% of cells at an intermediate level and in 15% at a high level. However, this high level does not reach the maximum level observed in the mature population.

We developed a new technique for enrichment of the mature CD4+ CD8- CD3+ thymocytes. We performed a negative selection with CD8, CD34, and CD10 antibodies. CD34 is expressed on very immature thymocytes (18), and CD10 is expressed early during thymocyte development but decreases with the increase of CD3 expression at the DP stage (54). The CD4+ mature population in the experiment in Fig. 1D was more than 94% (mean, 90.8 ± 2.9% for eight thymuses) CD3high and more than 90% CD69high (data not shown). Only 6.6% (mean, 9.7 ± 4.8 for eight thymuses) of these cells had an undetectable level of CD4, as shown in Fig. 1D. The mature CD4 unstained thymocytes, could be depleted by using an antibody against CD4, suggesting that they also express CD4 but at a low level.

Interaction with TEC favors HIV replication exclusively in the mature CD4+ CD8- CD3+ thymocytes. We first tested whether the individually enriched CD4+ subpopulations of thymocytes were capable of producing HIV at a high level when cocultured with TEC. Total thymocytes as well as subpopulations containing predominantly DP CD4+ CD8+ CD3±, immature CD4± CD8- CD3-, and mature CD4+ CD8- CD3+ cells were infected with the primary HIV-1B-LAIp isolate and cultured alone or cocultured with autologous TEC. HIV-1 replication was evaluated by measuring the p24gag antigen concentration in the culture supernatants at various times postinfection. No HIV replication was detected when total thymocytes or any of the CD4+ subpopulations were cultured in the absence of TEC (data not shown). In contrast, an efficient HIV replication was observed in coculture of autologous TEC with total thymocytes and exclusively with the subset of mature CD4+ CD8- CD3+ thymocytes, as shown in Fig. 2. Under our coculture conditions, the observed replication level for mature thymocytes obtained from nine thymuses corresponded to 1.5 to 33 ng of p24gag per ml. In each thymus, the level of replication observed in this specific subset was about 5- to 20-fold higher than that observed in total thymocytes. However, it is worth pointing out that virus entry was not impaired within the DP and immature thymocytes, as demonstrated by PCR analysis (data not shown).


View larger version (12K):
[in this window]
[in a new window]
  		FIG. 2.   Interaction with TEC favors high-level HIV replication exclusively in mature CD4+ CD8- CD3+ thymocytes. Freshly isolated total, immature CD4± CD8- CD3-, double-positive CD4+ CD8+ CD3±, or mature CD4+ CD8- CD3+ thymocytes were infected by HIV-1B-LAIp at a multiplicity of infection of 0.001 as described in Materials and Methods. Each subpopulation was cocultured with autologous TEC, and HIV replication was determined by measuring the p24gag concentration in the coculture supernatants on days 3, 6, 10, 13, and 17 postinfection. This experiment is representative of four experiments performed on four thymuses. Ag, antigen.

CD4+ CD8- CD3+ as well as intermediate CD4+ CD8- CD3- thymocytes sustain a high-level HIV replication in response to specific cytokines required for HIV replication. The cytokines mainly involved in HIV replication in total thymocytes during their interaction with TEC were previously determined as TNF, IL-1, IL-6, GM-CSF (45), and IL-7 (14). We first determined whether addition of these cytokines was sufficient to promote HIV replication in the mature CD4+ CD8- CD3+ subset. In parallel, we studied whether the absence of HIV replication in the DP and the immature subsets during their interaction with TEC was related to a possible unresponsiveness to these cytokines.

Therefore, total thymocytes, mature CD4+ CD8- CD3+, DP CD4+ CD8+ CD3±, and immature CD4± CD8- CD3- thymocytes were infected with HIV-1B-LAIp and were cultured in absence of TEC but treated with a mixture of TNF, IL-1, IL-6, IL-7, and GM-CSF. As shown in Fig. 3A, the role of these cytokines in inducing HIV replication in total thymocytes was confirmed. As expected, a 5- to 20-fold-increased replication (between 5 and 130 ng for eight thymuses) was observed in the mature CD4+ CD8- CD3+ subset under these conditions (Fig. 3A). In the experiment represented in Fig. 3A, despite an especially high-level replication in total and mature thymocytes, no detectable replication was observed in the DP subset. In contrast, the immature pool of thymocytes, although unable to produce the virus in the presence of TEC, was able to do so when stimulated with these cytokines. Because the immature population consists of two different thymocyte subsets (as mentioned above), we determined whether this high-level replication took place either in the TN CD4- CD8- CD3- or in the intermediate CD4+ CD8- CD3- subset or in both. We considered the TN subset because the permissivity of these cells was previously reported in relation to low CD4 expression under conditions of stimulation by mitogen (57). The TN subset was isolated by depleting the immature subset from CD4+ cells by negative selection with CD4 antibodies. As shown in Fig. 3B, the high-level HIV replication observed in the immature subset when they were treated with cytokines was not observed in the TN subset and therefore must have been restricted to the intermediate CD4+ CD8- CD3- subset (Fig. 3B).


View larger version (10K):
[in this window]
[in a new window]
  		FIG. 3.   The mature CD4+ CD8- CD3+ but also the intermediate CD4+ CD8- CD3- thymocytes sustain high-level HIV replication under stimulation with the mixture of cytokines (IL-1, IL-6, IL-7, GM-CSF, and TNF). (A) Freshly isolated total, immature CD4± CD8- CD3-, double-positive CD4+ CD8+ CD3±, and mature CD4+ CD8- CD3+ thymocytes were infected by the HIV-1B-LAIp isolate at a multiplicity of infection of 0.001. They were cultured with stimulation by a mixture of IL-1, IL-6, IL-7, GM-CSF, and TNF. HIV replication was determined by measuring the p24gag concentration in the coculture supernatants on days 3, 7, 10, and 14 postinfection. (B) Immature CD4± CD8- CD3- thymocytes (including intermediate CD4+ CD8- CD3- and TN CD4- CD8- CD3-) or immature thymocytes depleted from CD4+ cells resulting in the TN CD4- CD8- CD3- subset were infected by HIV-1B-LAIp at a multiplicity of infection of 0.001 and cultured with stimulation by a mixture of cytokines (IL-1, IL-6, IL-7, GM-CSF, and TNF). HIV replication was determined by measuring the p24gag concentration in the coculture supernatants on days 3, 6, 10, and 14 postinfection. This pattern of response of the different subpopulations to the cytokines is representative of three experiments performed on three different thymuses.

We then evaluated the relative importance of each of these cytokines in promoting HIV replication in total thymocytes and in the two responsive subsets, namely, the mature CD4+ CD8- CD3+ and the intermediate CD4+ CD8- CD3-.

Due to the need for a large number of cells, each population used in this experiment was obtained from a different thymus. The total population, the mature subset, and the immature CD4± CD8- CD3- pool (in which only the intermediate thymocytes replicate the virus) were infected by HIV-1B-LAIp and cultured at 2 × 106/well with either the mixture of all cytokines (TNF, IL-1, IL-6, IL-7, and GM-CSF) or with mixtures which each lacked one specific cytokine. As shown in Fig. 4A, we confirmed a crucial role of TNF and IL-7 in sustaining HIV replication in total thymocytes, since no detectable replication was observed in the absence of either one. The absence of GM-CSF resulted in a significant reduction of HIV replication. Comparison of Fig. 4B and C shows that TNF and IL-7 appear to play the same crucial role in mature and immature thymocytes whereas GM-CSF is an additional major factor only in immature thymocytes. The absence of IL-1 did not significantly affect HIV replication in either subpopulation, whereas the absence of IL-6 impaired the replication in the mature thymocytes exclusively.


View larger version (15K):
[in this window]
[in a new window]
  		FIG. 4.   TNF and IL-7 play a crucial role in mature CD4+ CD8- CD3+ and in immature CD4+ CD8- CD3- thymocytes, whereas GM-CSF is a major factor only in immature thymocytes. Each population used in this experiment, i.e., total (A), mature CD4+ CD8- CD3+ (B), and immature CD4± CD8- CD3- (C) was obtained from a different thymus. Thymocytes of each population were infected by HIV-1B-LAIp at a multiplicity of infection of 0.001, were seeded at 2 × 106 cells/ml, and cultured with the mixture of cytokines (IL-1, IL-6, IL-7, GM-CSF, and TNF) or with this mixture including all but one of these cytokines. HIV replication was determined by measuring the p24gag concentration in the culture supernatants on various days postinfection. For each subpopulation, this experiment is representative of three experiments performed with three different thymuses. Statistical analysis by the nonparametric test of Mann-Whitney gave the following significant differences between the different cytokine mixtures: for total thymocytes with all cytokines versus total thymocytes minus IL-7, P < 0.006; for all cytokines versus minus GM-CSF, P < 0.006; and for all cytokines versus minus TNF, P < 0.006; for mature thymocytes with all cytokines versus minus IL-7, P < 0.02; for all cytokines versus minus IL-6, P < 0.02; and for all cytokines versus minus TNF, P < 0.02; for the immature thymocytes with all cytokines versus minus IL-7, P < 0.006; for all cytokines versus minus GM-CSF, P < 0.006; and for all cytokines versus minus TNF, P < 0.01.

TNF secreted during interaction of thymocytes with TEC is crucial in inducing NF-kappa B-dependent replication since its absence during the specific interaction between intermediate thymocytes and TEC is responsible for an impaired replication. Since the lack of a high-level HIV replication within the intermediate subset was not due to their unresponsiveness to the specific cytokines required for replication, we examined an alternative hypothesis, i.e., that of a defect in the secretion of one or more of these cytokines during intermediate thymocyte-TEC interaction. To test this hypothesis, we first performed experiments in which the cytokines exhibiting a crucial role in the immature subset (TNF, IL-7, and GM-CSF) for HIV replication were added, individually to cocultures of infected intermediate thymocytes with TEC. As shown in Fig. 5, of the three factors tested, only TNF was able to promote a detectable HIV replication in the coculture. These data suggest that TNF is not secreted or is secreted in insufficient amounts during immature thymocyte-TEC interaction.


View larger version (17K):
[in this window]
[in a new window]
  		FIG. 5.   Defect in activation of TNF secretion during the TEC-immature-thymocyte interaction correlates with an impairment of HIV replication in the immature CD4+ CD8- CD3- thymocytes. Freshly isolated immature CD4± CD8- CD3- thymocytes were infected by the HIV-1B-LAIp isolate at a multiplicity of infection of 0.001. They were cocultured with autologous TEC with no additional stimulation (Control) or with TNF, IL-7, or GM-CSF. HIV replication was determined by measuring the p24gag concentration in the culture supernatants on various days postinfection. This experiment is representative of three experiments performed on three different thymuses.

In our previous report (14), we provided evidence that the activation of transcription factors of the Rel/NF-kappa B family is a requirement to promote efficient HIV replication in thymocytes. The prevalent NF-kappa B complex present in total freshly isolated thymocytes was shown to be the p50-p65 complex, whereas p50-p50 and p50-RelB complexes, although present, were less strongly represented. We also demonstrated that TNF, secreted during the coculture, is the cytokine mainly involved in the maintenance of NF-kappa B activity and that TNF signaling requires coactivation by IL-7. Here we first verified that the active p50-p65 complex actually resides in mature but not in immature thymocytes. NF-kappa B complexes were characterized, in mature CD4+ CD8- CD3+ and immature CD4± CD8- CD3- thymocytes freshly isolated from the same thymus, by electrophoretic mobility shift assay with antibodies specific for the different members of this family. As shown in Fig. 6A, in the freshly isolated CD4+ CD8- CD3+ thymocytes, antibodies against p50 abolished the binding of most complexes, antibodies against p65 abolished the binding of the upper complex, and antibodies against RelB did not modify the binding of any complex. This suggests that the p50-p50 and the p50-p65 complexes are the main representatives in this subset. In contrast, as shown in Fig. 6B, in freshly isolated immature thymocytes, the major complex was the transcriptionally inactive p50-p50, while the p50-p65 complex was hardly visible (antibody upshifting confirmed this interpretation [data not shown]). We also confirmed that TNF maintained p50-p65 activity in the mature CD4+ CD8- CD3+ thymocytes (Fig. 6A). As shown in Fig. 6B, this cytokine can induce p50-p65 activity also in the immature thymocytes cultured for 45 h, demonstrating again that the absence of p50-p65 complex in freshly isolated cells was not associated with a defect in responsiveness to this cytokine. In the two populations (mature and immature), IL-7 by itself does not induce p50-p65 but, rather, is a cofactor with TNF in the induction of p50-p65, as shown in Fig. 6. Therefore, convergent lines of evidence indicate that HIV replication cannot take place in intermediate thymocytes because of the absence of p50-p65 complex, essentially due to the impairment of TNF production during the interaction with TEC. In contrast, mature thymocytes fulfill the requirement for TNF secretion during coculture with TEC associated with an IL-7 secretion for an efficient NF-kappa B-dependent transcription of the viral genome.


View larger version (30K):
[in this window]
[in a new window]
  		FIG. 6.   Electrophoretic mobility shift assays. The p50-p65 complex is present in the freshly isolated mature CD4+ CD8- CD3+ thymocytes (A) but not in the immature CD4± CD8- CD3- ones (B). TNF and IL-7 coinduce this activity in both subsets. (A) Whole-cell extracts from freshly isolated mature CD4+ CD8- CD3+ thymocytes were preincubated either with a preimmune serum (control) or with antibodies against RelB, p65, or p50 before incubation with a 32P-labeled oligonucleotide representing the HIV long terminal repeat-derived kappa B motif. The positions of the two specific bands, p50-p65 and p50-p50, are indicated. Mature CD4+ CD8- CD3+ thymocytes were also cultured for 45 h either unstimulated (control) or stimulated with TNF, IL-7, or TNF plus IL-7, or cocultured with TEC as indicated. Whole-cell extracts from these various samples were incubated with a 32P-labeled oligonucleotide representing the HIV long terminal repeat-derived kappa B motif. (B) Immature CD4± CD8- CD3- thymocytes were freshly isolated or cultured for 45 h either unstimulated (control) or stimulated with TNF or with IL-7 or with TNF plus IL-7. Whole-cell extracts from these various samples were incubated with a 32P-labeled oligonucleotide representing the HIV long terminal repeat-derived kappa B motif. This experiment is representative of five experiments performed on five different thymuses.

IL-7 sustains expression of the p75 TNF receptor. The role of IL-7 as a cofactor of TNF in NF-kappa B activation was further investigated in the mature CD4+ CD8- CD3+ thymocytes. We determined the level of expression of the two TNF receptors, p55 and p75 (12), by immunostaining and flow cytometry in mature thymocytes either freshly isolated or maintained in culture for 4 days in the presence or absence of IL-7. As shown in Fig. 7A, p75 was detected in the mature thymocytes just after their isolation. However, p75 expression was not maintained in culture and was no longer detectable at 4 days unless IL-7 was added to the culture.


View larger version (23K):
[in this window]
[in a new window]
  		FIG. 7.   IL-7 maintains p75 TNF receptor expression on the mature CD4+ CD8- CD3+ thymocytes. The presence of two TNF receptors, p75 (A) and p55 (B), was determined by flow cytometry on the mature CD4+ CD8- CD3+ thymocytes, either freshly isolated or cultured for 4 days without IL-7 or with IL-7 as indicated. Thymocytes were stained with FITC anti-p75, FITC anti-p55, or FITC anti-IgG control. p75 and p55 fluorescence histograms are shown (solid line) in comparison with those obtained with the isotype-matched controls (broken line). This experiment is representative of three experiments performed on three different thymuses.

As shown in Fig. 7B, p55 expression, conversely to p75, persists in culture and IL-7 has no noticeable effect.


    DISCUSSION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

For a better evaluation of the consequences of HIV infection of the thymus, we investigated whether HIV replication was favored in thymocytes at certain stages of their differentiation. Our previous in vitro studies demonstrated the crucial role of interaction of thymocytes with TEC to produce a high-level virus replication. We pointed out the role of this interaction in creating a favorable cytokine microenvironment that was able to activate virus replication mainly through TNF, IL-1, IL-6 (45), and IL-7 (14), as well as in protecting thymocytes against apoptosis through GM-CSF (4, 25) and IL-7 (1, 22). These previous data have been obtained by infecting the total population of thymocytes with various primary isolates or laboratory strains (14, 45). In this study, we identified, within this total population, the subpopulations of thymocytes in which this high-level replication readily occurs with the HIV-1B-LAIp primary isolate. We obtained the same results with the molecular clone NL-4-3 (data not shown). In addition, we specified the characteristics of these cells which permit such a virus production. The first step of this work consisted of enriching the CD4+ subpopulations susceptible to HIV infection. Therefore, the various CD4+ populations were isolated on the basis of their level of expression of CD4 but also of CD3, a criterion of cell maturity. We developed methods to enrich these different subpopulations, avoiding nonspecific activation. In most cases, except for the DP thymocytes, negative selection was used. However, no activation subsequent to CD4 and CD8 cell sorting of these cells was observed since no virus replication was detectable. Figure 1 indicates the rate of enrichment of these subpopulations and the level of expression of the different markers within each subset. In particular, mature CD4+ CD8- CD3+ cells obtained by negative selection with CD8, CD10 and CD34 antibodies led to a subset of CD8- thymocytes that have undergone positive selection, as also indicated by the expression of CD69 (data not shown), associated with a strong expression of CD3 (28, 54). A small part of this population was determined to express CD4 at a low level. These cells probably represent a mature population that has undergone positive selection and downregulated both CD4 and CD8 before differentiation to single-positive CD4+ or CD8+ cells (13, 58), or they might also represent thymocytes expressing the gamma delta T-cell receptor described that do not express detectable levels of CD4 (38).

We first show that the population of mature CD4+ CD8- CD3+ thymocytes is the only one able to exhibit a high-level virus replication when cocultured with TEC (Fig. 2). HIV replication in the mature subpopulation was about 5- to 20-fold higher than that observed in total thymocytes, whereas this subset represents 1/20 of the total thymocytes. Since infection progresses in an exponential manner, we might have expected a more marked difference. This result may also suggest that within the total thymocytes, the other subpopulations facilitated HIV replication within the mature subset. No replication was detectable in the other CD4+ thymocytes including the intermediate CD4+ CD8- CD3- and the DP CD4+ CD8+ CD3± subsets cocultured with TEC (Fig. 2). The ability of these cells to be infected was not in doubt, as demonstrated by us (data not shown) and others (49, 55) by PCR analysis of the proviral genome or by expression of murine genes inserted into the nef (30) or vpr (26) region of HIV-1NL4-3 provirus. Together, these data indicate that some replication might occur in the other subsets but at very low levels, undetectable by p24gag determination in culture supernatants. In the TN and DP subsets, this absence of detectable replication is associated with unresponsiveness to the cytokines required for a high-level replication (TNF, IL-1, IL-6, IL-7, and GM-CSF) (Fig. 3). In contrast, the intermediate subset does not exhibit a defect in responsiveness to one or more of these cytokines, since these cells support a high level of replication in the presence of these cytokines (Fig. 3). We demonstrated that IL-7 and TNF are both required to support HIV replication in both the mature and intermediate subsets (Fig. 4B and C). In addition to the requirement for TNF and IL-7, a differential role of GM-CSF was observed. This cytokine was an additional important factor only in the immature subset (Fig. 4B and C). Therefore, the effect of GM-CSF observed in the total population of thymocytes reflects its ability to support viral replication essentially in the intermediate subpopulation. It is very likely that in the presence of TNF added to the culture, the synergistic role of IL-1 is hardly visible, since both cytokines act on NF-kappa B activation and since TNF signaling has the major effect (14). In contrast, the effect of IL-6 on HIV replication is restricted to the mature population. This is in agreement with the fact that this cytokine was shown to specifically induce the proliferation of this thymocyte subset (50).

The requirement for IL-7 might explain the absence of viral production in the DP cells, since most of them do not express the IL-7 receptor (51). However, according to the murine model, a small fraction of the DP cells (around 5%) which have undergone positive selection have acquired this receptor. We cannot exclude replication in this small fraction of DP cells, which might be masked by the high rate of apoptosis of the remaining 95% of the DP cells which are not protected by the antiapoptotic effect of IL-7 in culture. Response to TNF might not also be efficient in this set of DP cells, since TNF receptors are present on only 3% of the total population of thymocytes (46).

We previously demonstrated with the total population of thymocytes (14, 45) that TNF and IL-7 act synergistically to enhance HIV transcription through NF-kappa B transcription factors, with p50-p65 being the prevalent complex observed. We demonstrate here that the p50-p65 activity observed in the total population is clearly located in the freshly isolated mature thymocytes and is maintained either by coculture with TEC or by the synergistic effect of TNF and IL-7 (Fig. 6A). The major role of TNF in HIV replication in thymocytes was further confirmed by the fact that the only barrier to virus production in intermediate thymocytes was a defect in TNF production during their interaction with TEC. Indeed, addition of exogenous TNF to the coculture was sufficient to induce replication (Fig. 5). The relevance of the absence of an efficient stimulation by TNF in the microenvironment of the intermediate thymocytes was supported in vivo by the fact that these thymocytes, freshly isolated, are devoid of nuclear p50-p65 activity. The p50-p50 complex was observed, but this complex is transcriptionally inactive (19) (Fig. 6B). When added to the culture medium of these thymocytes, TNF induces the activation of p50-p65, suggesting again the lack of TNF in the microenvironment.

The role of IL-7 as a cofactor with TNF in the activation of NF-kappa B was further investigated in the mature thymocytes. We showed that TNF receptors p55 and p75 (12) were both expressed when cells were freshly isolated from their thymic environment. Culture of these cells led to a decrease of p75 expression, whereas p55 expression was much more stable. However, IL-7 was able to maintain p75 expression in culture but has no effect on p55 expression. It is worth noting that IL-7, known for its antiapoptotic role, favors the expression of the p75 receptor, which leads exclusively to NF-kappa B activation, and not that of the p55 receptor, which also leads to an apoptotic pathway. This increase in NF-kappa B, by itself, might serve to protect against apoptosis induced by TNF signaling through p55 (47). Since p55 expression is constitutively stable, this receptor might be sufficient to induce the NF-kappa B activation necessary for HIV replication even in absence of IL-7, but the higher rate of cell death (observed in the culture in absence of IL-7) might impair this process. This interpretation is supported by the data in the literature showing that only agonists of the p75 receptor lead to thymocyte activation, as shown by their proliferation, whereas agonists of p55 receptor mediate cytotoxicity (53). Since GM-CSF plays an important role in HIV replication in the immature population, we also tested its effect on the expression of the two TNF receptors. However, since the viability of the immature thymocytes is highly dependent on IL-7, we tested GM-CSF in the presence of IL-7 and found that the levels of the two TNF receptors were identical to those observed with IL-7 alone.

Taken together, these data led us to establish the following model for the dynamics of HIV replication in the thymus. Our study argues for a preferential replication within the mature CD4+ CD8- CD3+ thymocytes as a result of their interaction with TEC by a process involving TNF and IL-7 secretion. The presence of a high viral load in this population might be responsible in vivo for an increase of the peripheral viral load, explaining a rapid progression toward AIDS. We can also speculate that the intermediate thymocytes may contribute to viral spreading in the presence of TNF, secreted in their microenvironment, by inflammatory cells in response to infection of the mature population. This sequence of events was actually observed in the thymus of juvenile cats infected by feline immunodeficiency virus: a high level of virus was observed within mature thymocytes early postinfection, whereas infection of the immature thymocytes was seen later and was associated with the inflammatory response and cortical atrophy (62). Furthermore, infection of this immature population is upregulated by GM-CSF. This cytokine might act by increasing thymocyte viability (23, 29) or, as suggested previously (21), by increasing IL-7 receptor expression on the thymocyte surface (21). We cannot exclude the possibility that GM-CSF with TNF favors the differentiation of immature CD34+ thymocytes into dendritic cells (34). Indeed, we observed that addition of GM-CSF to immature CD4+ CD8- CD3- cells cultured with IL-7 and TNF is associated with the appearance of cells with dendritic morphology (data not shown). Dendritic cells were shown to strongly enhance HIV replication in T cells (43), and thymic dendritic cells were also found to support HIV replication (8). It is possible that dendritic differentiation and infection, in the immature compartment, also contributes to the inflammatory response. Such an inflammatory response, by favoring virus spreading, might lead to direct destruction of these cells (49) and disruption of the cortical microenvironment and may contribute to an irreversible adverse effect on T-cell regeneration.


    ACKNOWLEDGMENTS

L. Chêne and M.-T. Nugeyre contributed equally to this work.

We are very grateful to Sonia Berrih-Aknin and to Claude Planché (Hospital Marie-Lannelongue, Le Plessis-Robinson, France) for providing us with thymuses from infants undergoing cardiac surgery. We also thank Sonia Berrih-Aknin for helpful discussions. We thank R. H. Bassin for careful reading of the manuscript.

This work was supported by the Agence Nationale pour la Recherche sur le SIDA (ANRS). L. Chêne was a fellow of the French Ministry of Education and Research (MENESR). E. Guillemard was supported by a SIDACTION fellowship from Fondation pour la Recherche Médicale.


    FOOTNOTES

* Corresponding author. Mailing address: Unité de Biologie des Rétrovirus, Institut Pasteur, 25 rue du Dr Roux, 75724 Paris Cedex 15, France. Phone: 33 1 45 68 89 44/87 33. Fax: 33 1 45 68 89 57. E-mail: nisrael{at}pasteur.fr.


    REFERENCES
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

1. Akashi, K., M. Kondo, U. von Freeden-Jeffry, R. Murray, and I. L. Weissman. 1997. Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell 89:1033-1041[Medline].
2. Aldrovandi, G. M., G. Feuer, L. Gao, B. Jamieson, M. Kristeva, I. S. Y. Chen, and J. A. Zack. 1993. The SCID-hu mouse as a model for HIV-1 infection. Nature 363:732-736[Medline].
3. Autran, B., G. Carcelain, T. S. Li, C. Blanc, D. Mathez, R. Tubiana, C. Katlama, P. Debre, and J. Leibowitch. 1997. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 277:112-116[Abstract/Free Full Text].
4. Bach, M. K., and J. R. Brashler. 1995. Evidence that granulocyte/macrophage-colony-stimulating factor and interferon-gamma maintain the viability of human peripheral blood monocytes in part by their suppression of IL-10 production. Int. Arch. Allergy Immunol. 107:90-92[Medline].
5. Baldwin, A. S. 1996. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649-683[Medline].
6. Barré-Sinoussi, F., J.-C. Chermann, F. Rey, M.-T. Nugeyre, S. Chamaret, C. Axler-Blin, F. Vezinet-Brun, C. Rouzioux, W. Rozenbaum, and L. Montagnier. 1983. Isolation of a T lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220:868-870[Abstract/Free Full Text].
7. Baskin, G. B., M. Murphey-Corb, L. N. Martin, B. Davison-Fairburn, F.-S. Hu, and D. Kuebler. 1991. Thymus in simian immunodeficiency virus-infected rhesus monkeys. Lab. Investig. 65:400-407[Medline].
8. Beaulieu, S., A. Kessous, D. Landry, S. Montplaisir, D. Bergeron, and E. A. Cohen. 1996. In vitro characterization of purified human thymic dendritic cells infected with human immunodeficiency virus type 1. Virology 222:214-226[Medline].
9. Berkowitz, R. D., K. P. Bekerman, T. J. Schall, and J. M. McCune. 1998. CXCR4 and CCR5 expression delineates target for HIV-1 disruption of T cell differentiation. J. Immunol. 161:3702-3710[Abstract/Free Full Text].
10. Bonyhadi, M. L., L. Rabin, S. Salimi, D. A. Brown, J. Kosek, J. M. McCune, and H. Kaneshima. 1993. HIV induces thymus depletion in vivo. Nature 363:728-732[Medline].
11. Braun, J., H. Valentin, M. T. Nugeyre, H. Ohayon, P. Gounon, and F. Barré-Sinoussi. 1996. Productive and persistent infection of human thymic epithelial cells in vitro with HIV-1. Virology 225:413-418[Medline].
12. Brockhaus, M., H. J. Schoenfeld, E. J. Schlaeger, W. Hunzicher, W. Lesslauer, and H. Loetsher. 1990. Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc. Natl. Acad. Sci. USA 87:3127-3131[Abstract/Free Full Text].
13. Budd, R. C., and P. F. Mixter. 1995. The origin of CD4-CD8-TCRalpha beta + thymocytes: a model based on T-cell receptor avidity. Immunol. Today 16:428-431[Medline].
14. Chêne, L., M. T. Nugeyre, F. Barré-Sinoussi, and N. Israël. 1999. High-level replication of human immunodeficiency virus in thymocytes requires NF-kappa B activation through interaction with thymic epithelial cells. J. Virol. 73:2064-2073[Abstract/Free Full Text].
15. Coffin, J. M. 1995. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 267:483-489.
16. De Rossi, A., M.-L. Calabro, M. Panozzo, D. Bernardi, B. Caruzo, G. Tridente, and L. Chieco-Banchi. 1990. In vitro studies of HIV-1 infection in thymic lymphocytes: a putative role of the thymus in AIDS pathogenesis. AIDS Res. Hum. Retroviruses 6:287-297[Medline].
17. Douek, D. C., R. D. McFarland, P. H. Keiser, E. A. Gage, J. M. Massey, B. F. Haynes, M. A. Polis, A. T. Haase, M. B. Feinberg, J. L. Sullivan, B. D. Jamieson, J. A. Zack, L. J. Picker, and R. A. Koup. 1998. Changes in thymic function with age and during the treatment of HIV infection. Nature 396:690-695[Medline].
18. Galy, A., S. Verma, A. Barcena, and H. Spits. 1993. Precursors of CD3+CD4+CD8+ cells in the human thymus are defined by expression of CD34. Delineation of early events in human thymic development. J. Exp. Med. 178:391-401[Abstract/Free Full Text].
19. Hansen, S. K., L. Guerrini, and F. Blasi. 1994. Differential DNA sequence specificity and regulation of HIV-1 enhancer activity by crel-relA transcription factor. J. Biol. Chem. 269:22230-22237[Abstract/Free Full Text].
20. Hays, E. F., C. H. Uittenbogaart, J. C. Brewer, L. W. Vollger, and J. A. Zack. 1992. In vitro studies of HIV-1 expression in thymocytes from infants and children. AIDS 6:265-272[Medline].
21. Herbelin, A., F. Machavoine, A. Vicari, E. Schneider, M. Papiernik, H. Ziltener, C. Penit, and M. Dy. 1994. Endogenous granulocyte-macrophage colony-stimulating factor is involved in IL-1- and IL-7-induced murine thymocyte proliferation. J. Immunol. 153:1973-1981[Abstract].
22. Hernandez-Caselles, T., M. Martinez-Esparza, D. Sancho, G. Rubio, and P. Aparicio. 1995. Interleukin-7 rescues human activated T lymphocytes from apoptosis induced by glucocorticosteroids and regulates Bcl-2 and CD25 expression. Hum. Immunol. 43:181-189[Medline].
23. Ho, D. D., A. U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard, and M. Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123-126[Medline].
24. Israel, N., U. Hazan, J. Alcami, A. Munier, S. F. Arenzana, F. Bachelerie, A. Israel, and J. L. Virelizier. 1989. Tumor necrosis factor stimulates transcription of HIV-1 in human T lymphocytes, independently and synergistically with mitogens. J. Immunol. 143:3956-3960[Abstract].
25. Iversen, P. O., L. B. To, and A. F. Lopez. 1996. Apoptosis of hemopoietic cells by the human granulocyte-macrophage colony-stimulating factor mutant E21R. Proc. Natl. Acad. Sci. USA 93:2785-2789[Abstract/Free Full Text].
26. Jamieson, B. D., and J. A. Zack. 1998. In vivo pathogenesis of a human immunodeficiency virus type 1 reporter virus. J. Virol. 72:6520-6526[Abstract/Free Full Text].
27. Joshi, V. V., J. M. Oleske, S. Saad, C. Gadol, E. Connor, R. Bobila, and A. B. Minnefor. 1986. Thymus biopsy in children with acquired immunodeficiency syndrome. Arch. Pathol. Lab. Med. 110:837-842[Medline].
28. Jung, L. K. L., B. F. Haynes, S. Nakamura, S. Pahwa, and S. M. Fu. 1990. Expression of early activation antigen (CD69) during human T cell development. Clin. Exp. Immunol. 141:466-472.
29. Kinoshita, T., T. Yokoda, K. Arai, and A. Miyajima. 1995. Regulation of Bcl-2 expression by oncogenic Ras protein in hematopoietic cells. Oncogene 10:2207-2212[Medline].
30. Kitchen, S. G., C. H. Uittenbogaart, and J. A. Zack. 1997. Mechanism of human immunodeficiency virus type 1 localization in CD4-negative thymocytes---differentiation from a CD4-positive precursor allows productive infection. J. Virol. 71:5713-5722[Abstract].
31. Kitchen, S. G., and J. A. Zack. 1997. CXCR4 expression during lymphopoiesis: implications for human immunodeficiency virus type 1 infection of the thymus. J. Virol. 71:6928-6934[Abstract].
32. Kopp, E. B., and S. Ghosh. 1995. NF-kappa B and rel proteins in innate immunity. Adv. Immunol. 58:1-27[Medline].
33. Kraft, D. L., I. L. Weissman, and E. K. Waller. 1993. Differentiation of CD3-4-8- human fetal thymocytes in vivo: characterization of a CD3-4+8- intermediate. J. Exp. Med. 178:265-277[Abstract/Free Full Text].
34. Marquez, C., C. Trigueros, E. Fernandez, and M. L. Toribio. 1995. The development of T and non-T cell lineages from CD34+ human thymic precursors can be traced by the differential expression of CD44. J. Exp. Med. 181:475-483[Abstract/Free Full Text].
35. May, M. J., and S. Ghosh. 1997. Rel/NF-kappa B and I kappa B proteins: an overview. Semin. Cancer Biol. 8:63-73[Medline].
36. McCune, J. M. 1997. Thymic function in HIV-1 disease. Semin. Immunol. 9:397-404[Medline].
37. McCune, J. M., R. Loftus, D. K. Schmidt, P. Carroll, D. Webster, Y. L. Swor, I. R. Francis, B. H. Gross, and R. M. Grant. 1998. High prevalence of thymic tissue in adults with human immunodeficiency virus-1 infection. J. Clin. Investig. 101:2301-2308[Medline].
38. Moretta, L., E. Ciccone, S. Ferrini, P. G. Pelicci, M. C. Mingari, J. Zeromski, C. Bottino, C. Grossi, and A. Moretta. 1991. Molecular and cellular analysis of human T lymphocytes expressing gamma delta T-cell receptor. Immunol. Rev. 120:117-125[Medline].
39. Müller, J. G., V. Krenn, C. Schindler, S. Czub, C. Stahl-Hennig, C. Coulibaly, G. Hunsmann, C. Kneitz, T. Kerbau, A. Rethwilm, V. terMeulen, and H. K. Müller-Hermelink. 1993. Alteration of thymus cortical epithelium and interdigitating dendritic cells but no increase of thymocyte cell death in the early course of simian immunodeficiency virus infection. Am. J. Pathol. 143:699-713[Abstract].
40. Pakker, N. G., D. W. Notermans, R. de Boer, M. T. Roos, F. de Wolf, A. Hill, J. M. Leonard, S. A. Danner, F. Miedema, and P. T. Schellekens. 1998. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nat. Med. 4:208-214[Medline].
41. Papiernik, M., Y. Brossard, N. Mulliez, J. Roume, C. Brechot, F. Barin, A. Goudeau, J.-F. Bach, C. Griscelli, R. Henrion, and R. Vazeux. 1992. Thymic abnormalities in fetuses aborted from human immunodeficiency virus type 1 seropositive women. Pediatrics 89:297-301[Abstract/Free Full Text].
42. Pedroza-Martins, L., K. B. Gurney, B. E. Torbett, and C. Uittenbogaart. 1998. Differential tropism and replication kinetics of human immunodeficiency virus type 1 isolates in thymocytes: coreceptor expression allows viral entry, but productive infection of distinct subsets is determined at the postentry level. J. Virol. 72:9441-9452[Abstract/Free Full Text].
43. Pope, M., S. Gezelter, N. Gallo, L. Hoffman, and R. M. Steinman. 1995. Low levels of HIV-1 infection in cutaneous dendritic cells promote extensive viral replication upon binding to memory CD4+ T cells. J. Exp. Med. 182:2045-2056[Abstract/Free Full Text].
44. Rosenzweig, M., D. P. Clark, and G. N. Gaulton. 1993. Selective thymocyte depletion in neonatal HIV-1 thymic infection. AIDS 7:1601-1605[Medline].
45. Rothe, M., L. Chêne, M. Nugeyre, F. Barré-Sinoussi, and N. Israël. 1998. Contact with thymic epithelial cells as a prerequisite for cytokines enhanced HIV-1 replication in thymocytes. J. Virol. 72:5852-5861[Abstract/Free Full Text].
46. Ryffel, B., M. Brockhaus, B. Greiner, M. J. Mihatsh, and F. Gudat. 1991. Tumour necrosis factor receptor distribution in human lymphoid tissue. Immunology 74:446-452[Medline].
47. Sonenshein, G. E. 1997. Rel/NF-kappa B transcription factors and the control of apoptosis. Semin. Cancer Biol. 2:113-119.
48. Stanley, S. K., J. M. McCune, H. Kaneshima, J. S. Justement, M. Sullivan, E. Boone, M. Baseler, J. Adelsberger, M. Bonyhadi, J. Orenstein, C. H. Fox, and A. S. Fauci. 1993. Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse. J. Exp. Med. 178:1151-1163[Abstract/Free Full Text].
49. Su, L., H. Kaneshima, M. Bonyhadi, S. Salimi, D. Kraft, L. Rabin, and J. M. McCune. 1995. HIV-1-induced thymocyte depletion is associated with indirect cytopathogenicity and infection of progenitor cells in vivo. Immunity 2:25-36[Medline].
50. Suda, T., R. Murray, C. Guidos, and A. Zlotnik. 1990. Growth-promoting activity of IL-1 alpha, IL-6, and tumor necrosis factor-alpha in combination with IL-2, IL-4, or IL-7 on murine thymocytes. Differential effects on CD4/CD8 subsets and on CD3+/CD3- double-negative thymocytes. J. Immunol. 144:3039-3045[Abstract].
51. Sudo, T., S. Nishikawa, N. Ohno, N. Akiyama, M. Tamakoshi, H. Yoshida, and S. Nishikawa. 1993. Expression and function of the interleukin 7 receptor in murine lymphocytes. Proc. Natl. Acad. Sci. USA 90:9125-9129[Abstract/Free Full Text].